Edwards Lifesciences Corporation (EW) — Form 10-Q: Quarterly report

Edwards Lifesciences Corporation filed its quarterly report for the period ending September 30, 2026. Net sales for the first nine months of 2026 were $5.1 billion, representing an increase compared to the same period in 2025. The company reported net income and cash flow details alongside updates on product approvals and legal proceedings.